A growth model of neuroendocrine tumor surrogates and the efficacy of a novel somatostatin-receptor–guided antibody-drug conjugate: Perspectives on clinical response?
Year: 2019
Type: article
Source: Surgery
Institutions: University of Alabama at Birmingham, UAB Medicine
Language: English
Subfield: Epidemiology
Field: Medicine
Domain: Health Sciences
Open Access status: green
Funders: North American Neuroendocrine Tumor Society, University of Alabama at Birmingham, Center for Clinical and Translational Sciences, University of Texas Health Science Center at Houston, National Cancer Institute, National Institute of Diabetes and Digestive and Kidney Diseases, National Institute of Biomedical Imaging and Bioengineering, National Center for Advancing Translational Sciences
OpenAlex ID: W2973819962
